Rx: Restasis, BID. Patient understands that consistency of dosing and compliance of use are important to maintain stability of condition and minimize involved symptoms.
Laboratory testing may be directed toward identifying blood dyscrasias, clotting disorders and other hematological abnormalities. Suggested testing may include (but is not limited to) the following: ● Complete blood count with platelets (CBC with differential and platelets) ● CMB - comprehensive metabolic panel ● Prothrombin time (PT) ● Activated partial thromboplastin time (PTT) ● Activated partial thromboplastin time (APTT) ● An international ratio (INR) to rule out over-anticoagulation in patients taking blood thinners ● Antiphospholipid antibodies ● Homocysteine level, particularly in young men ● Assay for natural anticoagulants such as ...
Comments
Post a Comment